Omeros Corporation

NASDAQ:OMER

4.06 (USD) • At close June 14, 2024
Bedrijfsnaam Omeros Corporation
Symbool OMER
Munteenheid USD
Prijs 4.06
Beurswaarde 235,253,452
Dividendpercentage 0%
52-weken bereik 0.92 - 6.36
Industrie Biotechnology
Sector Healthcare
CEO Dr. Gregory A. Demopulos M.D.
Website https://www.omeros.com

An error occurred while fetching data.

Over Omeros Corporation

Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical programs include Narsoplimab (OMS721/MASP-2) that has completed pivotal studies for hematopoietic stem-cell transplant-associated

Vergelijkbare Aandelen

Co-Diagnostics, Inc. logo

Co-Diagnostics, Inc.

CODX

1.59 USD

Inozyme Pharma, Inc. logo

Inozyme Pharma, Inc.

INZY

4.74 USD

Milestone Pharmaceuticals Inc. logo

Milestone Pharmaceuticals Inc.

MIST

1.41 USD

OptiNose, Inc. logo

OptiNose, Inc.

OPTN

1.155 USD

CymaBay Therapeutics, Inc. logo

CymaBay Therapeutics, Inc.

CBAY

32.48 USD

Mainz Biomed B.V. logo

Mainz Biomed B.V.

MYNZ

0.625 USD

Aldeyra Therapeutics, Inc. logo

Aldeyra Therapeutics, Inc.

ALDX

3.73 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)